What does HER2 status mean for Stomach Cancer treatment

Stomach CancerMay 19, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

HER2 Status in Stomach Cancer: What You Need to Know

HER2 status is an important biomarker that helps determine which treatments may work best for stomach cancer patients. Let me explain what this means and how it influences treatment decisions.

What is HER2?

HER2 (Human Epidermal Growth Factor Receptor 2) is a protein found on the surface of some cancer cells. Think of it like a growth signal receiver—when HER2 is present in high amounts, it can tell cancer cells to grow and divide more rapidly.

When your pathology report mentions HER2 status, it's describing whether your stomach cancer cells have:

  • HER2-positive: High levels of HER2 protein (about 15-20% of stomach cancers)
  • HER2-negative: Low or no HER2 protein
  • HER2-equivocal: Borderline results requiring additional testing

How HER2 Status Affects Treatment Decisions

For HER2-Positive Stomach Cancer:

If your cancer is HER2-positive, this actually opens up additional treatment options. According to NCCN (National Comprehensive Cancer Network) Guidelines for gastric cancer, HER2-positive status is a key factor that oncologists consider when selecting chemotherapy regimens and targeted therapies.

The clinical reasoning works like this: Doctors can use targeted therapies (medications that specifically attack HER2-positive cells) in combination with standard chemotherapy. This targeted approach can be more effective because it directly addresses the growth signal that HER2-positive cancer cells rely on.

For HER2-Negative Stomach Cancer:

If your cancer is HER2-negative, your oncologist will focus on other treatment pathways, which may include standard chemotherapy combinations and consideration of other biomarkers (like microsatellite instability or PD-L1 status).

Questions to Ask Your Oncologist

Since HER2 status significantly influences your treatment plan, here are specific questions to discuss with your care team:

  1. "What is my HER2 status, and how does this affect my treatment options?"
  2. "Are there targeted therapies available for my specific HER2 status?"
  3. "What are the benefits and side effects of the treatment approach you're recommending?"
  4. "Are there clinical trials available that match my HER2 status and other tumor characteristics?"
  5. "How will we monitor whether the treatment is working?"

Important Context

Your HER2 status is just one piece of your complete clinical picture. Your oncologist will also consider:

  • The stage of your cancer
  • Your overall health and performance status
  • Other biomarkers in your tumor
  • Your personal preferences and goals

Your oncologist will determine the most appropriate treatment approach for YOUR specific case based on your complete medical evaluation.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: